Insider trades

David W. Osborne, Chief Officer of Arcutis Biotherapeutics ARQT, has filed 0 purchases and 4 sales on the open market. The latest trade was on 23/03/06.

David W. Osborne

Chief Technical Officer
First filing
23/03/02
Trades
6 trades
Buys / sales
0 / 4
12-month net buying
No record
Last trade
23/03/06

Trading activity

Transactions

Trade type
Open-market sale23/03/0623/03/08690 sh$15.26$10,529.4−0.3%
ARQT
Open-market sale23/02/28–23/03/0223/03/022,005 sh3 trades$15.96avg.$32,006.8−0.8%